STAAR Surgical to Host Third Quarter 2026 Earnings Call on November 4, 2026
STAAR Surgical Company announced it will hold a conference call and webcast to discuss its third quarter 2026 financial results on November 4, 2026.
Stocks · News reference
Stifel analyst Thomas Stephan upgrades Staar Surgical (NASDAQ:STAA) from Hold to Buy and raises the price target from $28 to $31.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
STAAR Surgical Company announced it will hold a conference call and webcast to discuss its third quarter 2026 financial results on November 4, 2026.
Filed: 2026-10-05 AccNo: 0001193125-26-413763 Size: 242 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stifel upgraded STAAR Surgical to Buy, while raising its price target, citing China momentum, EVO+ mix and upside to 2026-27 estimates.
Analysts upgraded STAA, NFLX, SFIX, with ratings moving toward Buy or Neutral and mixed price-target changes.